AABB promotes coverage and reimbursement policies that support patients’ access to blood products, and transfusion services and cellular therapies. The Association educates policymakers, payers, blood centers and providers on the complexities of coding, billing and reimbursement policies, and advocates for improved coverage and reimbursement policies.
AABB Seeks Feedback to Shape Updates to 2023 Billing Guide
March 07, 2023
CMS Clarifies Billing Procedures for CAR T-Cell Therapy
January 18, 2023
CMS Shares Plans to Improve Medicare Beneficiaries’ Access to Emerging Technologies
October 19, 2022